Biosurgical Agents – Market Insights – US

The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2032.

Increasing surgical procedure volumes in the US will largely dictate growth of the US biosurgical agent market.

Which surgical procedures contribute most to biosurgical agent revenues in the US region?

How will declining procedure volumes in certain surgical specialties affect market growth?

Product penetration by surgical specialty will influence overall market trends.

Which specialty type has the highest penetration in the biosurgical agent market?

Which biosurgical agent materials are most popular and drive unit sales within each specialty?

The US biosurgical agent market has strong competition.

Which products will enjoy more rapid adoption and why?

What recent changes have occurred in the competitive landscape of this market?

Which are the top competitors and what factors contributed to their market position?

Table of contents